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Abstract
Detection of the rare polymorphisms and causative mutations of genetic diseases in a targeted genomic area has become a
major goal in order to understand genomic and phenotypic variability. We have interrogated repeat-masked regions of
8.9 Mb on human chromosomes 21 (7.8 Mb) and 7 (1.1 Mb) from an individual from the International HapMap Project
(NA12872). We have optimized a method of genomic selection for high throughput sequencing. Microarray-based selection
and sequencing resulted in 260-fold enrichment, with 41% of reads mapping to the target region. 83% of SNPs in the
targeted region had at least 4-fold sequence coverage and 54% at least 15-fold. When assaying HapMap SNPs in NA12872,
our sequence genotypes are 91.3% concordant in regions with coverage$4-fold, and 97.9% concordant in regions with
coverage$15-fold. About 81% of the SNPs recovered with both thresholds are listed in dbSNP. We observed that regions
with low sequence coverage occur in close proximity to low-complexity DNA. Validation experiments using Sanger
sequencing were performed for 46 SNPs with 15-20 fold coverage, with a confirmation rate of 96%, suggesting that DNA
selection provides an accurate and cost-effective method for identifying rare genomic variants.
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Introduction
The completion of a human genome reference sequence has
opened new horizons for genetic analyses and biomedical research
[1,2]. Recent advances in sequencing technologies now permit the
resequencing of individual genomes. A total of five individual
human genomes have been published to date. J.C. Venter’s
genome was sequenced using the Sanger method [3], while J.
Watson’s genome was completed using 454 massively parallel
sequencing and cost one hundredth [4] of the Venter’s genome
[5]. The three genomes of Yoruban and Asian individuals, as well
as a leukaemia genome were sequenced by a massively parallel
approach using reversible terminator chemistry (Illumina-sequenc-
ing [6,7,8,9]). Despite these advances, the cost of sequencing a
human genome remains high for routine diagnostic purposes.
Applications such as mapping and identifying disease-associated
regions do not require the sequencing of an entire genome. The
ability to genotype common polymorphisms with SNP arrays has
greatly enhanced the mapping of disease-associated loci [10].
Recent studies have demonstrated the potential power of
resequencing candidate genes to detect rare variants underlying
disease-associated traits or to identify somatic mutations associated
with tumors [11,12,13,14,15,16,17]. However, de novo discovery of
pathogenic mutations for inherited or sporadic disease is limited by
the low throughput of current targeted sequencing methodologies.
For many genetic diseases the genomic interval of a causative
mutation is localized using linkage and association studies
[18,19,20]. To allow cost-effective resequencing of these loci,
recent studies proposed a microarray-based method for selection
of a portion of a genome that could then be sequenced. This
method exploits tiling oligonucleotide arrays to select specific
regions of genomic DNA by hybridization, and the enriched
sample is subsequently sequenced by high throughput methods.
This approach was successfully applied to the sequencing of both
discontinuous exonic sequences, and contiguous genomic regions
[21,22,23]. Alternatively, DNA capture trials have also been
performed using in-solution hybridization to biotinylated BAC or
RNA probes [24,25].
The goal of this study was to demonstrate the feasibility to
sequence a selected fraction of a genome at low cost employing
custom design tiling arrays and high throughput sequencing. The
repeat-masked region of 8.9 Mb corresponding to a contiguous
sequence of 15 Mb was targeted on human chromosomes 21 and
7. We demonstrate that this method can be applied to accurately
define sequence variants in contiguous stretches of genomic DNA
and could be used to identify pathogenic mutations in patients.
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Sample preparation
Genomic DNA isolated from a lymphoblastoid cell line of
HapMap individual NA12872 was used in this study. 20 ug of
DNA in 500 ul H2O was sonicated on ice using a Branson 450
sonifier (10% amplitude, 150 seconds, using pulses of 0.5 sec on,
0.5 sec off). The length of sonicated fragments varied between 100
and 700 bp. The library size was estimated by electrophoresis in a
2% agarose gel. DNA was precipitated with salt/isopropanol.
End filling of DNA breaks was performed in 200 ul (18U T4
DNA Polymerase, 60U T4 Polynucleotide Kinase, NEB T4 DNA
Polymerase Buffer with BSA, 1 mM dNTP, 0.5 mM ATP (New
England Biolabs)) for 20 minutes at 12uC, 20 minutes at 25uC, and
20 minutes at 75uC. DNA was purified with phenol:chloroform:i-
soamyl alcohol (25:24:1) and precipitated with salt/isopropanol.
A-tailing was performed in a volume of 50 ul (5U Taq polymerase,
1x PCR buffer, 4 uM dATP, (New England Biolabs)) for 45 min at
72uC. Y-tailed Illumina adapters were used, that allow amplifica-
tion from 2 different primers complementary to single strand tails
of the adapter (Genomic DNA/ChIP-Seq oligonucleotide se-
quences at http://intron.ccam.uchc.edu/groups/tgcore/wiki/
013c0/Solexa_Library_Primer_Sequences.html). Sticky end liga-
tion was performed on the A-tailed sample DNA using T4 DNA
ligase (New England Biolabs) and a 6-fold molar excess of Y-tailed
adapters with 39 T overhang according to the manufacturer’s
protocol. The sample was PCR amplified in four 50 ul reactions
using standard Illumina primers and the following conditions:
95uC for 2 minutes, followed by 30 cycles of 95uC for 30 seconds,
63uC for 30 seconds and 72uC for 60 seconds, then at 72uC for 5
minutes.
20 ug of amplification products were precipitated and mixed
with 100 ug COT-1 DNA (Roche). Amplified samples were
hybridized to capture arrays for approximately 60 h at 42uC with
active mixing using a MAUI hybridization station. After
hybridization, arrays were washed at room temperature for 2
minutes with Stringent Wash Buffer, 2 mins with Wash Buffer I,
1 min with Wash Buffer II, and 15 seconds with Wash Buffer III
(Nimblegen). Slides were dried, and captured DNA fragments
were eluted on a hotplate at 95uC using two 250 ul aliquots of
water. Eluted DNA was lyophilized and amplified using the same
primers, and the same conditions as above.
A custom array designproduced byNimblegen (www.nimblegen.
com) was used. Probe design was performed using the repeat-
masked sequence of human chromosome 21 (hg17) and ENCODE
region ENm001, comprising a total length of 8.9 Mb (7.8 Mb of
chr21 and 1.1 Mb of ENm001). In total, 385,000 probes with an
average length of 50 bp were used to cover the entire region, with
an average density of one probe per 22 bp. The array design is
accessible from MIAMExpress database (http://www.ebi.ac.uk/
miamexpress/) with the accession number A-MEXP-1601.
High throughput single-end sequencing was performed using
the Illumina GA-II instrument. 36 cycles of reversible terminator
chemistry reaction were performed with sequencing kit- SBS v 2.0,
tiles – 100. For the initial handling of the data standard Illumina
Analysis Pipeline GAPipeline-1.0rc4 was used.
Parallel experiments on the same array design were conducted,
with and without addition of COT-1 DNA. For the enrichment
without COT-1 one lane of Illumina flow-cell was run, and for the
experiment with COT-1, two such lanes were run.
The whole experiment including library preparation, hybrid-
ization, sequencing and analysis of polymorphisms could be
performed within two weeks. The total cost of the experiment is
mainly comprised of the cost of the array and sequencing.
Sequence analysis
We first took the set of reads produced by the Illumina pipeline
and determined using fetchGWI software [26] the reads with an
exact match on the UCSC hg18 reference genome. The results,
presented in Table 1, indicate that only 13% of the reads find an
exact match, and 85% of the reads exhibit variants or sequencing
errors. We then used Rolexa software [27] to improve the quality
of the reads. The Rolexa software pipeline utilizes the image
intensity files produced by the Illumina sequencing equipment and
performs base calling to produce the sequence reads. The software
accept parameters that determine how stringently the nucleotides
are discriminated between fully qualified bases (A, C, G, and T), or
degenerate bases (using the IUPAC codes) when the intensity files
indicate that the probabilities associated with each of the 4 possible
nucleotides do not allow an unambiguous base calling. We
performed 3 runs of the Rolexa software, each with a different set
of parameters. Results are shown in table 1. We used the reads
produced by the relaxed parameter set since the number of reads
with no exact matches fitted the best to our expectation of ,45%
that was calculated based on the Illumina error rates and expected
frequency of SNPs. As the basic error rate in Illumina reads is
,1%, approximately one third of the 36 nt reads will contain an
error, so about 33% of the reads are expected to not match exactly
the reference sequence. Including SNPs in this calculation, some
predictions estimate ,1 SNP per 300 nt. Assuming that reads are
placed randomly in the genome, we expect the reads to start at
each possible nucleotide along the sequence. Since the reads are
36 nt in length, for each SNP we will have 36 different reads that
contain the SNP and thus will not match exactly to the reference
genome, while the remaining 264 starting positions along a 300 nt
stretch will match exactly, equating to ,12% of reads containing
Table 1. Number of sequence reads extracted from intensity files using Illumina and Rolexa analysis.
Method Total reads
Uniquely mappable
reads/bases
%o f
reads
Reads/bases with
multiple genomic
matches
%o f
reads Missed reads/bases
%o f
reads
Illumina default pipeline 33,280,140 4,335,125/155,820,008 13 779,445/27,968,664 2 28,165,570/1,002,508,008 85
Rolexa default parameters
log2(c(1.5,2.5,3.5))
10,217,510 5,430,218/165,755,132 53 1,189,132/33,511,489 12 3,598,160/100,396,369 35
Rolexa strict parameters
(log2(c(1.05,2.5,3.5)))
4,138,591 2,789,546/78,062,584 67 555,370/14,964,244 14 793,675/21,821,150 19
Rolexa relaxed parameters
(log2(c(1.9,2.9,3.9)))
23,022,818 4,109,921/132,362,857 18 830,843/25,786,098 4 18,082,054/545,943,814 78
doi:10.1371/journal.pone.0006659.t001
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33%+12%=45% of reads with mismatches.
The Rolexa produces reads of different length, between 25 nt
and 36 nt.
A total of 23 million reads with sufficient length and quality were
obtained. 4,109,921 reads found a unique match (group U of
unique reads), 830,843 reads found multiple matches (group R of
repeated reads), and 18,082,054 reads remained with no match
(group M of missed reads). 1,751,305 of the U reads (42%) were
mapped to the target region (1,605,903 unique reads originate from
HSA21 and 143,407 reads – from HSA7). 2,358,616 unique reads
originate from non-target regions. The file containing Rolexa raw
reads is accessible at the http://home.adm.unige.ch/,nikolaev/
Rolexa_relaxed.rar. Enrichment was calculated as a ratio of the
number of reads with a match within the selected region divided by
the length of the region, and the number with a match outside the
selected region divided by the length of the rest of repeat-masked
portion of the genome.
The regions with the low sequence coverage and the regions
from the third quartile of the coverage distribution were selected in
a way that at least 80% of their length should be comprised of the
nucleotides covered less than 3 fold and between 16 and 29 fold
respectively. Low-complexity DNA was detected using the dust
program [28] with a parameter -10.
In order to discover polymorphisms in the sequenced regions,
reads with no exact match on the reference genome (group M)
were analyzed to determine their best alignment to the genome.
We have found a number of limitations of Maq [29] and Eland [7]
aligners such as the incapability of processing reads of different
lengths simultaneously, that precludes using these programs for
processing the Rolexa output. Rolexa reads were therefore aligned
to the reference genomic sequence using the global alignment
software align0 using the method described hereafter.
First we selected from each group of reads (U, R, and M) those
that have a high chance of finding a good quality alignment with
the chromosomal regions of interest by requiring that they share at
least a common 12-mer with the region, using the tagger tool from
the fetchGWI software package.
SNPs were predicted when an observed difference between the
reads and reference sequence occurred at a sufficient rate among
all the reads that cover the position. In this case we required at
least 4 reads to call a SNP and that the minor allele is present in at
least 20% of reads.
Results and Discussion
Enrichment for the targeted DNA sequences
In order to characterize sequence variants in a genomic region of
interest, we performed microarray-based enrichment using genomic
DNA from HapMap individual NA12872. The selected region
includes 8.9 Mb of non-repetitive DNA from human chromosome
21 (31.6 Mb–46.9 Mb) and chromosome 7 (115.3 Mb–117.2 Mb). A
sample from HapMap individual was chosen in order to compare the
variants identified in this study by sequencing with those genotyped
previously [30]. The enriched sample was sequenced using an Illumina
GAII instrument, and signals extracted using both the Illumina default
output and our own Rolexa analysis [27]. The selection procedure
resulted in 260-fold enrichment of the target region when the sample
was mixed with COT-1 DNA at the hybridization step. Figure 1
displays all 4.1 million sequence tags recovered by Rolexa that map
unambiguously to the reference genome. The high density of reads on
HSA21 corresponds to the target region plotted on the capture array,
and the second enrichment peak on HSA7 corresponds to ENCODE
region ENm001.
We checked if unique reads from outside the target region
cluster in the genome. The crude analysis have shown that the
average coverage is similar in all chromosomes (mean=0.03 and
standard deviation=0.007) suggesting that such reads do not
originate from a specific locus in a genome. We found out that
only 5% of unique reads from outside the target region comprise
clusters. 3594 clusters with an average coverage of more than 1
and the region length over 200 bp were detected. 78% of these
regions overlap to repeats, and 3% overlap to the regions of
segmental duplications longer than 1000 bp. Out of 184 segmental
duplications from the target region of HSA21 we observe
increased sequence coverage for 95 outside the target region.
The challenging problem at the enrichment step is to deplete the
repeated elements. The presence of repeats in the enriched sample
diminishes the specificity of sequencing of the target region and
increases the sequencing cost. After the COT-1 hybridization the
number of reads that correspond to repeats vary from 15% to 40%
of all mappable reads depending on the signal extraction criteria
and blast parameters.
Optimization of the microarray-based genomic
enrichment
We optimized the enrichment protocol in order to improve the
specificity of sequencing. Sonicated DNA was ligated with Y-tailed
adapters that include sequencing primers. The sample material
was amplified using Illumina primers to generate sufficient
quantities required for hybridization. When the amount of starting
material is limited, Whole Genome Amplification before sonica-
tion could provide the necessary DNA quantity.
The sample DNA was mixed with a five-fold excess of COT-1
DNA in order to reduce the proportion of non-specific
hybridization of repetitive DNA. After elution of the hybridized
fraction of the sample we performed PCR with primers
complementary to the adapters in order to restore double stranded
library and to reduce the relative abundance of COT-1 DNA.
Next we compared the results of hybridizations with and
without COT-1 DNA. In order to better understand the impact of
COT-1 DNA on the enrichment we assessed how efficiently it
competes for hybridization with repetitive elements. We compared
the proportion of Illumina reads that map to different kinds
repeats (with and without COT) to the proportion of these
elements in a genome (Fig. 2). Generally, addition of COT-1 DNA
during array hybridization reduced the proportion of repetitive
elements present in the captured DNA by 33%, thereby increasing
the percentage of reads from non-repetitive genomic elements, and
improving enrichment for the target sequence ,14-fold.
More specifically, addition of COT-1 reduced the proportion of
LINE elements in the enriched sample by 2-fold and the
proportion of Satellite repeats by 10-fold. COT-1 did not
significantly reduce the amount of SINEs. However, contrary to
the other repetitive elements, after array enrichment and
sequencing the proportion of satellite sequences was still
substantially higher than that expected compared to their
prevalence in the genome. With the current enrichment, out of
all reads that could be mapped back to the human genome,
satellites comprise 4.5%, LINEs 10.5%, and SINEs 11.4% (in the
genome satellites comprise 0.45%, LINEs - 21.1% and SINEs –
13.5%). Apart from repeats we also observed that 26% of uniquely
mappable reads obtained after enrichment were located outside
the target region. A possible explanation for their abundance is
that random species of sample DNA non-specifically anneal to the
single stranded DNA hybridized to the array probe by the primer,
which in our case is 57 bp. This length of the primer might be
sufficient to form a stable double stranded DNA hybrid; shorter
Targeted DNA Selection
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Further improvements to the enrichment could be made with
excess of primers to the hybridization mix to saturate the single
stranded ends of the sample DNA.
Standard Illumina pipeline vs. Rolexa
The Rolexa algorithm uses a probabilistic base-calling method
which allows detection of low-quality bases, assigning them either
as ambiguous sites, or alternatively trimming the read length. We
compared the final sequence assembly generated by extraction of
sequence signals using the standard Illumina output (GAPipeline-
1.0rc4 for LF) against that generated using the Rolexa algorithm
[27]. Using Rolexa default paremeters, the number of reads with a
unique perfect match in the reference genome increased by 20%
compared to the standard Illumina pipeline (5,430,218 versus
4,335,125, Table 1). The enrichment efficiency for our target
sequence remained almost the same in the two algorithms (255-
fold enrichment for Illumina versus 260-fold for Rolexa).
We observed that out of all mappable reads to the reference
genome, about 42% correspond to the target region, equating to a
16-fold median coverage, interquartile range 6- to 29-fold. A total
of 7.3% of the target region had no coverage, while 83% had at
least 4-fold coverage, and more than a half of the target region is
covered at least 15 times (Fig. 3). Previous estimates [7] suggest
that a read depth of 15-fold could identify ,97% of SNPs.
In order to identify factors influencing the variation in sequence
coverage between different genomic regions, we analyzed the
sequence and probe properties of the target region. We divided
our target loci into two groups: regions with less than 3-fold
coverage, and with 16–29 fold coverage (corresponding to the
third quartile of the sequence coverage distribution) (Fig. 4). We
observed that regions with low coverage are shorter (med-
ian=139 bp) than regions with the good coverage (med-
ian=227 bp) (Fig. 4b). The Nimblegen probes contain almost
no low complexity DNA on the array (Fig. 4c), but we observed
that the regions of low coverage contain much more low
complexity DNA compared to the regions with the good coverage
(Fig. 4d). Next we observed that regions of low coverage and
corresponding probes are AT rich relative to the genome average
(median GC content=0.3, genome average=0.41) (Fig. 4e,f). As
the array design used in this study is isothermal, and adenine-
thymine (A-T) base pair have lower energy than guanine–cytosine
Figure 1. Enrichment of target regions. All sequencing tags that map uniquely to the reference human genome are displayed in blue. The height
of peaks corresponds to the number of tags mapping to the same location. Red circles represent genomic areas plotted on the array. The image was
generated using Genome Graphs (http://genome.ucsc.edu/cgi-bin/hgGenome).
doi:10.1371/journal.pone.0006659.g001
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length=56 bp) than in regions which yield good sequence
coverage (median=45 bp, Fig. 4a). This also results in a lower
mean annealing temperature of probes in the low coverage regions
(median=71.6uC) compared to the regions with the good
coverage (median=77.5uC, Fig. 4g).
Figure 3. Distribution of nucleotide coverage in the targeted 7.8 Mb region of chromosome 21. The numbers in the boxes are the
percentages of the target region covered more than 4, 8 and 15 folds.
doi:10.1371/journal.pone.0006659.g003
Figure 2. Proportion of different genomic elements in the captured samples with and without COT-I DNA as compared to their
relative abundance in the human genome. Reads were mapped to the reference human genome using BLAT, allowing 2 mismatches and 1
indel with a minimal perfect match of 30 bp.
doi:10.1371/journal.pone.0006659.g002
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with low-complexity DNA. We hypothesized that this phenome-
non may be an artifact resulting from the inability to uniquely map
short Illumina reads from these regions to the Human Genome.
To test this, we re-mapped reads that match multiple genomic loci
(group R) to the regions of low-coverage, this time randomly
assigning ambiguously mapping reads to one of their genomic
matches. We observed that the coverage increased to a median of
4-fold (interquartile range 2–6 fold), with a maximal coverage of
69-fold. After this step, only four regions in our target loci
remained without coverage (criteria of less than 3 fold coverage
over 80% of the region). Thus we conclude that poor coverage for
some genomic loci does not result from an inability to capture
these loci with the array design used, but instead is attributable to
the difficulty of uniquely mapping short sequence reads back to the
reference genome in regions of reduced complexity. Protocols for
paired-end sequencing at 75 bp may reduce the proportion of
reads that have multiple matches in the genome and originate in
low-complexity DNA regions. This problem can also be reduced
with the use of mapping algorithms that do not discard reads
without a unique genomic match.
SNP detection
We next performed SNP and indel calling using fetchGWI [26],
align0 [29], and perl scripts. In order to extract SNP information
from the target region we selected a threshold for SNP calling such
that a variant should be seen in at least in 4 independent reads.
Thus we required a minimal coverage of 4-fold for homozygous
SNPs and 8-fold for heterozygous SNPs. Using these criteria we
were able to extract data for homozygous SNPs from 83% of the
target region (6.5 Mb) and heterozygous SNPs from 72% of the
region (5.6 Mb), recovering a total of 9025 putative variants (3212
homozygous and 5797 heterozygous, Table 2, Fig. 5). A total of
81% of the identified variants are present in dbSNP (www.ncbi.
Figure 4. Distribution of sequence features of regions and corresponding probes with low (,3 fold) and normal (15-29 fold)
sequence coverage. A,B) Length of the regions/probes. C,D) Percentage of low complexity DNA inside the regions/probes. E,F) GC content of
regions/probes. G) Hybridization temperature of the probes.
doi:10.1371/journal.pone.0006659.g004
Table 2. Numbers of homozygous and heterozygous SNPs identified in NA12782 at different sequence coverage thresholds.
Categories of SNPs All SNPs Heterozygous SNPs Homozygous SNPs
All SNPs identified with $4-fold coverage 9009 5797 3212
All SNPs identified with $15-fold coverage 6090 4224 1866
dbSNPs identified with $4-fold coverage 7350 4302 3048
dbSNPs identified with $15-fold 4846 3081 1765
HapMap SNPs identified with $4-fold coverage 3788 2122 1666
HapMap SNPs identified with $15-fold coverage 2810 1745 1065
New SNPs identified with $4-fold coverage 1659 1495 164
New SNPs identified with $15-fold coverage 1244 1143 101
doi:10.1371/journal.pone.0006659.t002
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ed in human individual genomes have shown that in the Watson
genome 82% of all variants were present in dbSNP, 74% in a
Yoruban genome, and 86% in an Asian genome [5,7,8]. Thus our
analysis is consistent with expectations from previously sequenced
genomes, suggesting the false positive rate after sequence capture
is similar to previous whole-genome studies. We were able to
confirm 91.3% of all SNPs identified in NA12872 by the HapMap
study, suggesting a low false negative rate in our analysis (Table 3).
In order to identify new SNPs in the target region, we first
examined the distributions of heterozygous and homozygous
variants from dbSNP (Fig. 6). We then set a threshold for assigning
a SNP to a hetero- or homozygous state based on the intersection
of the distributions, corresponding to 14% of minor allele
frequency (below this threshold the SNP was considered
homozygous, and above heterozygous). Interestingly, while 36%
of SNPs already present in dbSNP were identified as homozygous
in NA12872, out of the 1659 new SNPs we identified, only 8%
were homozygous. This observation can best be explained if many
of the novel SNPs identified are rare variants that are therefore
unlikely to be found in the homozygous state. This hypothesis
predicts that the shape of the distribution of allele percentages in
new SNPs should be the same as in the training set. Indeed this is
the case for homozygous SNPs, but for heterozygous SNPs it is
different (Fig. 6). This suggests that a fraction of putative new
heterozygous SNPs we detect might be false positives.
In the part of the target region that is covered at least 15 times
we detect 137 indels, among those, 65 indels overlap to dbSNP
positions and 17 are annotated in NA12872. Thus 53% of
detected indels are novel. The median indel length obtained is
8 bp. Interestingly, 39% of detected indels are heterozygous. The
frequency of indels observed is 1.8–3 times smaller than recovered
in the two individual genomes sequenced with Illumina technology
[7,8].
Lowering the coverage threshold to 3 increases the overlap
between our data and dbSNP from 91.3% to 93.7%. However, the
number of putative variants increased from 9025 to 27616,
suggesting that this relaxed threshold results in a dramatic increase
in the false positive rate.
Previous de novo sequencing studies have suggested a minimum
of 15-fold sequence coverage is required for robust identification of
heterozygous SNPs [7]. Based on this observation, we selected
6090 homozygous and heterozygous SNPs from the target region
with at least 15-fold coverage. 60% of all dbSNP positions located
in the target region represented on our enrichment array were
present at or above this threshold. With this coverage threshold we
correctly identified 97.9% of dbSNPs, 6.6% better compared to
when a minimum coverage of 4 fold was used.
Figure 5. Histogram of dbSNP positions coverage on chromosome 21.
doi:10.1371/journal.pone.0006659.g005
Table 3. Comparison of SNPs recovered in this study using
different thresholds of sequence coverage (4- and 15-fold)
with HapMap SNPs.
Categories of SNPs 4 fold % 15 fold %
All tested dbSNPs from the target
region
13147 100 7930 100
Concordant SNPs 12009 91.3 7765 97.9
Discordant SNPs (homozygous in
HapMap)
139 1.1 63 0.8
Discordant SNPs (heterozygous in
HapMap)
999 7.6 102 1.3
doi:10.1371/journal.pone.0006659.t003
Figure 6. Distribution of percentages of a minor variant for
SNPs as recovered by Illumina sequencing. Red: homozygous
SNPs, blue: heterozygous SNPs. Solid line: HapMap SNPs, dashed line:
new SNPs.
doi:10.1371/journal.pone.0006659.g006
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some 21 (excluding the family of KRTAP10 genes). We observed
162 SNPs in the Coding Sequences (CDS), among those 58 were
non-synonymous (Table 4). On average we detect 1.1 SNPs per
gene CDS a value concordant with previous estimations where this
value varies from 0.5 to 3.7 [31,32]. The proportion of new
variants among coding SNPs is roughly the same as among all
detected SNPs ,20%. 37% of all coding SNPs are homozygous;
this is higher than that observed for all SNPs (,30%).
SNP validation
106 SNPs and 30 indels detected in this study were selected for
validation by Sanger sequencing. We were able to confirm 80% of
all SNPs and 87% of indels (Table 5). In order to assess how the
depth of coverage impacts on the accuracy of SNP detection, we
divided the selected SNPs into two categories: (1) those with 15-40-
fold coverage, and (2) those with.40-fold coverage. 96% of SNPs
from the first group are confirmed, while the rate of false positives
in the second group is much higher, reaching 32%. The high rate
of false positives among highly covered SNPs might be explained
by non-specific hybridization of low-complexity DNA. Thus the
variants identified in low-complexity DNA should be treated with
caution since they contain many false positives.
Among tested SNPs, 90% of new SNPs and 100% of dbSNPs
with15-40-fold coverage are confirmed by Sanger sequencing.
This suggests a high SNP prediction potential of the method.
Ideally for heterozygous SNPs, each allele should be present in
50% of overlapping reads, and for homozygous SNPs all reads
should show the same nucleotide. Practically, the distribution of
the alleles in our experiment is different, as shown in Figure 6. We
selected heterozygous SNPs which were present in (i) 35–50% of
reads, and (ii) 20–30% of reads, and homozygous SNPs which
were observed in 86–100% of overlapping reads. As expected,
heterozygous SNPs with allelic ratios closer to 50:50 have a false
positive rate 2.8 times lower than SNPs with allelic ratios in the
range 20:80 to 30:70. All homozygous SNPs tested were
confirmed.
We conclude that microarray based selection followed by
Illumina sequencing is a powerful technique for de novo SNP and
short indel identification in specific genomic loci. Our analysis
efficiently recovers SNPs from the genomic loci with the normal
sequence complexity. Interestingly, the presence of low complexity
DNA inside the target region results in reduced sequence coverage
because of the difficulty to map uniquely the short Illumina reads
and will require additional efforts in order to produce sufficient
sequence coverage required for accurate SNP identification.
Conversely, regions of unusually high sequence coverage also
often correspond to low complexity DNA that exhibits an
increased rate of false positive SNPs, and which should therefore
be treated with caution. Further we show that putative
heterozygous SNP positions that are present at the expected
50:50 allelic ratio are the most robust predictions with lowest false
positive rate.
Given that the current cost of whole genome sequencing
remains high for routine analysis of large populations, techniques
that allow targeted sequencing of defined genomic regions are
valuable tools to facilitate the search for causative mutations in
genetic disease cases when prior information regarding the
location of a mutation is available. Continuing increases in
throughput will further decrease the cost of targeted resequencing.
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Table 4. SNPs in the coding sequences of the genes from the
target region.
Categories All SNPs
Synonymous
SNPs
Non-Synonymous
SNPs
All coding SNPs 162 85 77
dbSNPs 130 72 58
new SNPs 32 13 19
homozygous 60 31 29
heterozygous 103 54 49
doi:10.1371/journal.pone.0006659.t004
Table 5. SNP validation with Sanger sequencing.
All SNPs New SNPs dbSNPs Indels
Confirmed FALSE %False all Confirmed FALSE %False all Confirmed FALSE %False all Confirmed FALSE %False all
All SNPs 85 21 19.8 106 37 16 30.2 53 48 5 9.4 53 26 4 13.3 30
15–40 fold 44 2 4.3 46 18 2 10.0 20 26 0 0.0 26 - - - -
.40 fold 41 19 31.7 60 19 14 42.4 33 22 5 18.5 27 - - - -
35–50%
het
- --- 2 4 5 1 7 . 2 2 9 - --- - ---
20–30%
het
- --- 1 0 9 4 7 . 4 1 9 - --- - ---
0–14%
hom
- --- 5 0 0 . 0 5 - --- - ---
‘‘False’’ – number of false positives, ‘‘% False’’ – percentage of false positives. ‘‘15–40 fold’’ and ‘‘.40 fold’’ - indicate the groups of SNPs with different sequence
coverage. ‘‘35–50% het’’, ‘‘35–50% het’’ and ‘‘0–14% hom’’ – indicate the groups of heterozygous and homozygous putative new SNPs with different percentages of the
minor allele. ‘‘-’’ – the value is not calculated.
doi:10.1371/journal.pone.0006659.t005
Targeted DNA Selection
PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e6659References
1. IHGS C (2004) Finishing the euchromatic sequence of the human genome.
Nature 431: 931–945.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial
sequencing and analysis of the human genome. Nature 409: 860–921.
3. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, et al. (2007) The diploid genome
sequence of an individual human. PLoS Biol 5: e254.
4. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, et al. (2005) Genome
sequencing in microfabricated high-density picolitre reactors. Nature 437:
376–380.
5. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, et al. (2008) The
complete genome of an individual by massively parallel DNA sequencing.
Nature 452: 872–876.
6. Bentley DR (2006) Whole-genome re-sequencing. Curr Opin Genet Dev 16:
545–552.
7. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, et al.
(2008) Accurate whole human genome sequencing using reversible terminator
chemistry. Nature 456: 53–59.
8. Wang J, Wang W, Li R, Li Y, Tian G, et al. (2008) The diploid genome
sequence of an Asian individual. Nature 456: 60–65.
9. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, et al. (2008) DNA
sequencing of a cytogenetically normal acute myeloid leukaemia genome.
Nature 456: 66–72.
10. Altshuler D, Daly MJ, Lander ES (2008) Genetic mapping in human disease.
Science 322: 881–888.
11. Fokstuen S, Lyle R, Munoz A, Gehrig C, Lerch R, et al. (2008) A DNA
resequencing array for pathogenic mutation detection in hypertrophic
cardiomyopathy. Hum Mutat 29: 879–885.
12. Liu C, Aronow BJ, Jegga AG, Wang N, Miethke A, et al. (2007) Novel
resequencing chip customized to diagnose mutations in patients with inherited
syndromes of intrahepatic cholestasis. Gastroenterology 132: 119–126.
13. Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, et al. (2004) The
Human MitoChip: a high-throughput sequencing microarray for mitochondrial
mutation detection. Genome Res 14: 812–819.
14. Mandal MN, Heckenlively JR, Burch T, Chen L, Vasireddy V, et al. (2005)
Sequencing arrays for screening multiple genes associated with early-onset
human retinal degenerations on a high-throughput platform. Invest Ophthalmol
Vis Sci 46: 3355–3362.
15. van Eijsden RG, Gerards M, Eijssen LM, Hendrickx AT, Jongbloed RJ, et al.
(2006) Chip-based mtDNA mutation screening enables fast and reliable genetic
diagnosis of OXPHOS patients. Genet Med 8: 620–627.
16. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007)
Patterns of somatic mutation in human cancer genomes. Nature 446: 153–158.
17. Topol EJ, Frazer KA (2007) The resequencing imperative. Nat Genet 39:
439–440.
18. Beneyto MM, Cuevas JM, Millan JM, Espinos C, Mateu E, et al. (2000)
Prevalence of 2314delG mutation in Spanish patients with Usher syndrome type
II (USH2). Ophthalmic Genet 21: 123–128.
19. Dauvilliers Y, Blouin JL, Neidhart E, Carlander B, Eliaou JF, et al. (2004) A
narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q. Ann
Neurol 56: 382–388.
20. Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, et al. (2006) Genomewide
association analysis of human narcolepsy and a new resistance gene. Am J Hum
Genet 79: 252–263.
21. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, et al. (2007) Direct
selection of human genomic loci by microarray hybridization. Nat Methods 4:
903–905.
22. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, et al. (2007) Genome-wide
in situ exon capture for selective resequencing. Nat Genet 39: 1522–1527.
23. Okou DT, Steinberg KM, Middle C, Cutler DJ, Albert TJ, et al. (2007)
Microarray-based genomic selection for high-throughput resequencing. Nat
Methods 4: 907–909.
24. Bashiardes S, Veile R, Helms C, Mardis ER, Bowcock AM, et al. (2005) Direct
genomic selection. Nat Methods 2: 63–69.
25. Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, et al. (2009) Solution
hybrid selection with ultra-long oligonucleotides for massively parallel targeted
sequencing. Nat Biotechnol 27: 182–189.
26. Iseli C, Ambrosini G, Bucher P, Jongeneel CV (2007) Indexing strategies for
rapid searches of short words in genome sequences. PLoS ONE 2: e579.
27. Rougemont J, Amzallag A, Iseli C, Farinelli L, Xenarios I, et al. (2008)
Probabilistic base calling of Solexa sequencing data. BMC Bioinformatics 9: 431.
28. Morgulis A, Gertz EM, Schaffer AA, Agarwala R (2006) A fast and symmetric
DUST implementation to mask low-complexity DNA sequences. J Comput Biol
13: 1028–1040.
29. Li H, Ruan J, Durbin R (2008) Mapping short DNA sequencing reads and
calling variants using mapping quality scores. Genome Res 18: 1851–1858.
30. HapMap_consortium (2003) The International HapMap Project. Nature 426:
789–796.
3 1 .C a r g i l lM ,A l t s h u l e rD ,I r e l a n dJ ,S k l a rP ,A r d l i eK ,e ta l .( 1 9 9 9 )
Characterization of single-nucleotide polymorphisms in coding regions of
human genes. Nat Genet 22: 231–238.
32. Ng PC, Levy S, Huang J, Stockwell TB, Walenz BP, et al. (2008) Genetic
variation in an individual human exome. PLoS Genet 4: e1000160.
Targeted DNA Selection
PLoS ONE | www.plosone.org 9 August 2009 | Volume 4 | Issue 8 | e6659